Agonist, antagonist, and inverse agonist characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a selective δ-opioid receptor ligand

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 2, 2002, Pages 661-671

  Martin, Nancy A ^a   Ruckle, Michael B ^a   Vanhoof, Stephanie L ^a   Prather, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4 TETRAHYDROISOQUINOLINE PHENYLALANYLPHENYLALANINE; ADENYLATE CYCLASE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANINE NUCLEOTIDE; OPIATE AGONIST; OPIATE ANTAGONIST; SIGMA OPIATE RECEPTOR; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; CELL MEMBRANE PERMEABILITY; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); LIGANDS; OLIGOPEPTIDES; RATS; RECEPTORS, OPIOID, DELTA; TETRAHYDROISOQUINOLINES; TUMOR CELLS, CULTURED;

EID: 0036228370     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.2.661     Document Type: Article

References (37)

1. 35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: Evidence for an organized association of mu-opioid receptors and G protein
2. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition
3. 35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
4. Transducin, rhodopsin and 3′5′-cyclic GMP phosphodiesterase: Typical G protein mediated transduction system
5. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction
6. BW373U86: A nonpeptidic delta-opioid agonist with novel recopter-G protein-mediated actions in rat brain membranes and neuroblastoma cells
7. Differential regulation by guanine nucleotides or opiate agonist and antagonist receptor interactions
8. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor
9. Drug efficacy at guanine nucleotide-binding regulatory protein linked receptors: Thermodynamic interpretations of negative antagonism and of receptor activity in the absence of ligand
10. ICI 174864: A highly selective antagonist for the opioid delta-receptor
11. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice
12. Myristoylation of an inhibitory GTP-binding protein α-subunit is essential for its membrane attachment
13. Inverse, protean, and ligand-selective agonism: Matters of receptor conformation
14. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors
15. Opiate regulation of adenosine 3′:5′-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect
16. Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18tG2 and neuroblastoma x glioma NG108-15 hybrid cell lines
17. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
18. Lipid modifications of G proteins: α-subunits are palmitoylated
19. Chronic exposure to μ-opioid agonists produces constitutive activation of μ-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment
20. Agonist activity of the delta-antagonists TIPP and TIPP[psi] in cellular models expressing endogenous and transfected delta-opioid receptors
21. Switching agonist/antagonist properties of opiate alkaloids at the δ-opioid receptor using mutations based on the structure of the orphanin FQ receptor
22. Regulation of spontaneous activity of the δ-opioid receptor: Studies of inverse agonism in intact cells
23. Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities
24. Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts
25. Constitutive activity of the δ-opioid receptor expressed in C6 glioma cells: Identification of non-peptide δ-inverse agonists
26. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]-enkephalin in the mouse
27. Roles mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse
28. Opioid analgesics and antagonists
29. Evidence for distinct subcellular sites of opiate receptors
30. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: Development of a class of potent and highly delta-selective peptide antagonists
31. The TIPP opioid peptide family: Development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists
32. Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics
33. Lipid rafts and signal transduction
34. G proteins and opioid receptor-mediated signalling
35. Delta opioid modulation of the binding of guanosine-5′-O-(3- [35S]thio)triphosphate to NG-108-15 cell membranes: Characterization of agonist and inverse agonist effects
36. Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands
37. Coupling of human delta-opioid receptor to retinal rod transducin in Chinese hamster ovary cells